Gracell venture holdings limited
WebGracell Biotechnologies Inc., a clinical-stage biopharmaceutical company, primarily discovers and develops cell therapies for the treatment of cancer in the People's … WebFeb 25, 2024 · SUZHOU and SHANGHAI, China, Feb. 25, 2024 /PRNewswire/ -- Gracell Biotechnologies, Co., Ltd. ("Gracell") announced the completion of its $85 million series B funding today. The financing was led by Temasek with Lilly Asia Ventures, Kington Capital, King Star Capital and Chengdu Miaoji also participating in the round. This new funding …
Gracell venture holdings limited
Did you know?
WebFeb 25, 2024 · Gracell's mission is to bring best-in-class and affordable cellular medicines to cancer patients. About Temasek Founded in 1974, Temasek is an international investment company based in Singapore.... WebCompany profile page for Gracell Biotechnology Shanghai Co Ltd including stock price, company news, press releases, executives, board members, and contact information
WebNov 15, 2024 · Gracell. Nov 15, 2024, 10:00 ET. SHANGHAI and SUZHOU, China, Nov. 15, 2024 /PRNewswire/ -- Gracell Biotechnologies Co., Ltd. ("Gracell"), a clinical-stage immune cell therapy company, today ... WebAug 16, 2024 · SUZHOU and SHANGHAI, China, and PALO ALTO, Calif., Aug. 16, 2024 /PRNewswire/ -- Gracell Biotechnologies Inc. (NASDAQ: GRCL) ("Gracell"), a global clinical-stage biopharmaceutical company...
WebFeb 25, 2024 · SUZHOU and SHANGHAI, China, October 28, 2024 -- Gracell Biotechnologies Inc. (“Gracell”), a global clinical-stage biopharmaceutical company dedicated to developing highly efficacious and affordable cell therapies for the treatment of cancer, today announced it has secured $100 million in Series C funding. WebGracell Venture Holdings Limited US$ 9,799 May 10, 2024 US$ 0.9999 Sertus Nominees (Cayman) Limited U$ 0.0001 Options Directors, executive officers, employees and …
WebFeb 25, 2024 · Gracell Biotechnologies, Co., Ltd. announced that it has received $85 million in its series B round of funding led by Temasek Holdings Limited on February 25, 2024. ... Biotechnologies, Co., Ltd. announced that it has received $85 million in its series B round of funding led by Temasek Holdings Limited on February 25, 2024. The transaction ...
WebBack to GRCL Overview. Institutional Holdings information is filed by major institutions on form 13-F with the Securities and Exchange Commission. Major institutions are defined … reached nadirWebJan 12, 2024 · Gracell Biotechnologies Inc. ("Gracell") is a global clinical-stage biopharmaceutical company dedicated to discovering and developing breakthrough cell therapies. reached my limitWebFeb 27, 2024 · Gracell focuses on developing cellular therapeutics for hematological malignancy, solid tumor, or degenerative disease patients. It offers gene editing platform for antibody engineering, expression editing, and gene editing for treating solid cancer. reached movieWebApr 11, 2024 · GRACELL BIOTECHNOLOGIES INC. : Shareholders Board Members Managers and Company Profile US38406L1035 MarketScreener Homepage Equities United States Nasdaq Gracell Biotechnologies Inc. Company GRCL US38406L1035 GRACELL BIOTECHNOLOGIES INC. (GRCL) Add to my list Report Summary Quotes … reached my breaking pointWebDec 22, 2024 · Investors in the firm have invested at least $107.9 million and include Gracell Venture Holdings (founder Cao), TLS Beta Pte., … reached my wits endWebLists Featuring This Company. Banking Companies With Fewer Than 100 Employees (Top 10K) 9,611 Number of Organizations • $23.1B Total Funding Amount • 4,835 Number of … how to start a junkyardWebGracell Venture Holdings Limited is a company incorporated in the British Virgin Islands. Gracell Venture Holdings Limited is wholly owned by Land Blossom Limited, a … reached my goal